Cellectar Biosciences Inc
NASDAQ:CLRB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cellectar Biosciences Inc
NASDAQ:CLRB
|
US |
|
Acme United Corp
F:UT1
|
US |
|
S
|
Standard Capital Markets Ltd
BSE:511700
|
IN |
|
M
|
Mobimo Holding AG
XMUN:M1H
|
CH |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
Kingsrose Mining Ltd
ASX:KRM
|
AU |
|
R
|
Right Tunnelling PCL
SET:RT
|
TH |
|
A
|
Adsouth Partners Inc
OTC:ASPR
|
US |
Intrinsic Value
Is CLRB undervalued or overvalued?
See the intrinsic value estimate for Cellectar Biosciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CLRB looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CLRB’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Cellectar Biosciences Does
Cellectar Biosciences is a clinical-stage biopharma company focused on cancer drugs. It builds therapies around a phospholipid drug conjugate platform, which is designed to carry cancer-killing drugs more directly to tumor cells while limiting exposure to healthy tissue. Its work is centered on developing treatment candidates for hard-to-treat blood cancers and solid tumors.
- Headquarters
- United States of America US
- Employees
- 11
- IPO date
- May 20, 2005
Revenue & Expenses Breakdown
Cellectar Biosciences Inc
Earnings Waterfall
Cellectar Biosciences Inc
The intrinsic value for Cellectar Biosciences Inc (CLRB) under the Base Case is hidden USD.
Compared with the current market price of 1.19 USD, the stock appears hidden.